-
11.6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD 有权
Title translation: 6-(5-羟基-1H-吡唑-1-基)烟酰胺抑制剂公开(公告)号:US09345713B2
公开(公告)日:2016-05-24
申请号:US14693110
申请日:2015-04-22
Applicant: Takeda Pharmaceutical Company Limited
Inventor: Jason W. Brown , Melinda Davis , Anthony Ivetac , Benjamin Jones , Andre A. Kiryanov , Jon Kuehler , Marion Lanier , Joanne Miura , Sean Murphy , Xiaolun Wang
IPC: A61K31/496 , A61K31/551 , A61K31/5513 , C07D401/04 , C07D401/14 , C07D405/14 , C07D413/14 , C07D491/107 , C07D417/14 , C07D471/08 , C07D487/06 , C07D487/10 , C07D491/10 , A61K31/444 , A61K31/4545 , A61K31/4985 , A61K31/5377
CPC classification number: C07D401/14 , A61K31/444 , A61K31/4545 , A61K31/496 , A61K31/4985 , A61K31/5377 , A61K31/551 , A61K31/5513 , C07D401/04 , C07D405/14 , C07D413/14 , C07D417/14 , C07D471/08 , C07D487/04 , C07D487/06 , C07D487/10 , C07D491/10 , C07D491/107
Abstract: The present invention provides a method of treating acute heart failure by administering a compound of the formula: or a pharmaceutically acceptable salt thereof.
Abstract translation: 本发明提供了通过给予下式化合物或其药学上可接受的盐治疗急性心力衰竭的方法。